Associated Papers
CCK-B/Gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides.
Bläker M et al.
Molecular Pharmacology, 2000
Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists.
Bläker M et al.
Molecular Pharmacology, 1998
Select a paper to view details